Business of Cannabis: New York 2025 – Key Takeaways
Business of Cannabis: New York 2025 arrived at a crucial moment not just for the local cannabis industry, but for...
A comprehensive analysis of the international medical cannabis supply chain — examining country-specific data on exports, imports, market size, domestic production, and distribution landscapes. Understand the driving forces behind global supply dynamics, the impact of telemedicine on patient access, and regulatory changes shaping the market.
Be the first to receive the Global Medical Cannabis Market Review 2026 when it publishes in January.
Business of Cannabis: New York 2025 arrived at a crucial moment not just for the local cannabis industry, but for...
President Donald Trump has called on Senate Republicans to invoke the so-called ‘nuclear option’ to break the month-long government shutdown,...
Europe’s leading cannabis policy, business and investment conference — bringing senior decision-makers together in Paris.
Business of Cannabis: New York 2025 arrived at a crucial moment not just for the local cannabis industry, but for...
President Donald Trump has called on Senate Republicans to invoke the so-called ‘nuclear option’ to break the month-long government shutdown,...
As New Yorkers prepare to head to the polls to vote for their new Mayor tomorrow (Tuesday, November 04), the...
Next Thursday, 6 November 2025, Business of Cannabis: New York returns to The Wythe Hotel, Williamsburg, uniting more than 300...
Oregon-based edibles company Grön has weighed in on the ongoing controversy surrounding New York’s so-called ‘rent-a-licence’ scandal. The dispute follows...
On Tuesday, November 25, nearly 200 healthcare professionals, patient advocates, cannabis educators, and industry leaders converged on London's Conway Hall for...
First published on Cannabis Health Medical cannabis patients made history in London with a first-of-its-kind, patient-led education event focused on...
Business of Cannabis: New York 2025 arrived at a crucial moment not just for the local cannabis industry, but for...
The UK’s medical cannabis industry is now the second largest in Europe, second only to Germany, thanks to consistent and...
The campaign has been launched by European specialty pharmaceutical company, Neuraxpharm, which is focused on the treatment of central nervous...
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.